132 related articles for article (PubMed ID: 33028492)
1. Administration of erlotinib in apple juice overcomes decreased absorption in a rat model of gastric acid suppression.
Shimada T; Okano M; Yamada M; Ogawa Y; Ueda A; Nagase K; Sai Y
Drug Metab Pharmacokinet; 2020 Dec; 35(6):534-538. PubMed ID: 33028492
[TBL] [Abstract][Full Text] [Related]
2. Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.
van Leeuwen RW; Peric R; Hussaarts KG; Kienhuis E; IJzerman NS; de Bruijn P; van der Leest C; Codrington H; Kloover JS; van der Holt B; Aerts JG; van Gelder T; Mathijssen RH
J Clin Oncol; 2016 Apr; 34(12):1309-14. PubMed ID: 26858332
[TBL] [Abstract][Full Text] [Related]
3. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
4. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
[TBL] [Abstract][Full Text] [Related]
5. Effects of Proton Pump Inhibitor Coadministration on the Plasma Concentration of Erlotinib in Patients With Non-Small Cell Lung Cancer.
Ohgami M; Kaburagi T; Kurosawa A; Doki K; Shiozawa T; Hizawa N; Homma M
Ther Drug Monit; 2018 Dec; 40(6):699-704. PubMed ID: 29995672
[TBL] [Abstract][Full Text] [Related]
6. Sodium citrate buffer improves pazopanib solubility and absorption in gastric acid-suppressed rat model.
Muhammad HJ; Shimada T; Fujita A; Sai Y
Drug Metab Pharmacokinet; 2024 Apr; 55():100995. PubMed ID: 38447327
[TBL] [Abstract][Full Text] [Related]
7. Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats.
Yasumuro O; Uchida S; Kashiwagura Y; Suzuki A; Tanaka S; Inui N; Watanabe H; Namiki N
Xenobiotica; 2018 Nov; 48(11):1106-1112. PubMed ID: 29057719
[TBL] [Abstract][Full Text] [Related]
8. The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues.
Waisberg M; Black WD; Chan DY; Hale BA
Food Chem Toxicol; 2005 May; 43(5):775-82. PubMed ID: 15778018
[TBL] [Abstract][Full Text] [Related]
9. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287
[TBL] [Abstract][Full Text] [Related]
10. Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite.
Sanches-Lopes JM; Ferreira GC; Pinheiro LC; Kemp R; Tanus-Santos JE
Biochem Pharmacol; 2020 Jul; 177():113940. PubMed ID: 32224135
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of Fruit Juice-Drug Interactions Due to Osmolality-Dependent Fluid Secretion: Differences among Apple, Orange, and Grapefruit Juices.
Takemura M; Inoue K; Tamai I; Shirasaka Y
Biol Pharm Bull; 2024; 47(1):72-78. PubMed ID: 38171780
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
13. Antiulcer and gastric antisecretory effects of Landolphia owariensis extracts in rats.
Olaleye SB; Owoyele VB; Odukanmi AO
Niger J Physiol Sci; 2008; 23(1-2):23-6. PubMed ID: 19434209
[TBL] [Abstract][Full Text] [Related]
14. [Effect of long-term administration of antisecretary drugs on rat gastric histamine synthesis and acid secretion--compare with omeprazole and cimetidine].
Morita R; Harasawa S; Miwa T; Matsumoto M
Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2551-8. PubMed ID: 1404968
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
16. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Nagai H
Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Hilton JF; Tu D; Seymour L; Shepherd FA; Bradbury PA
Lung Cancer; 2013 Oct; 82(1):136-42. PubMed ID: 23910908
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors on the secretion of bicarbonates and pepsinogen induced by chemical stimulation of the gastric mucosa.
Zolotarev VA; Khropycheva RP
Bull Exp Biol Med; 2013 Feb; 154(4):415-8. PubMed ID: 23486568
[TBL] [Abstract][Full Text] [Related]
19. Gastric pH in Rats: Key Determinant for Preclinical Evaluation of pH-dependent Oral Drug Absorption.
Šíma M; Kutinová-Canová N; Ryšánek P; Hořínková J; Moškořová D; Slanař O
Prague Med Rep; 2019; 120(1):5-9. PubMed ID: 31103048
[TBL] [Abstract][Full Text] [Related]
20. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
